Avenue Therapeutics Files $50M Mixed Shelf
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avenue Therapeutics Inc (ATXI)Avenue Therapeutics Inc stock price live, this page displays NASDAQ ATXI stock exchange data. View the ATXI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avenue Therapeutics Inc real time stock price chart below.
What Is the Avenue Therapeutics Inc Stock Price Today?
The Avenue Therapeutics Inc stock price today is 1.860.
What Is the Stock Symbol for Avenue Therapeutics Inc?
The stock symbol for Avenue Therapeutics Inc is "ATXI."
What Stock Exchange Does Avenue Therapeutics Inc Trade On?
Avenue Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Avenue Therapeutics Inc a Good Stock to Buy?
Determining whether Avenue Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATXI quote. (ISIN: US05360L4032)
What Is the Avenue Therapeutics Inc Stock Price Today?
The Avenue Therapeutics Inc stock price today is 1.860.
What Is the Stock Symbol for Avenue Therapeutics Inc?
The stock symbol for Avenue Therapeutics Inc is "ATXI."
What Stock Exchange Does Avenue Therapeutics Inc Trade On?
Avenue Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Avenue Therapeutics Inc a Good Stock to Buy?
Determining whether Avenue Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATXI quote. (ISIN: US05360L4032)
NASDAQ
Currency in USD
1.860
0.000(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.810
1.900
52 wk Range
1.600
26.468
ATXI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8101.900
52 wk Range
1.60026.468
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATXI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
8.000
Upside
+330.108%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Avenue Therapeutics stock hits 52-week low at $1.89
- Investing.com
- Avenue Therapeutics stock hits 52-week low at $2.17
- Investing.com
- Avenue Therapeutics stock hits 52-week low at $1.68
- Investing.com
- Avenue Therapeutics Files $50M Mixed Shelf
- Investing.com
- Avenue Therapeutics stock hits 52-week low at $1.68
- Investing.com
- Avenue Therapeutics stock hits 52-week low at $1.89
- Investing.com
Avenue Therapeutics Inc Company Profile
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Compare ATXI to Peers and Sector
Metrics to compare | ATXI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATXIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −0.4x | −0.6x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 1.4x | 0.9x | 2.6x | |
Price / LTM Sales | - | 0.8x | 3.2x | |
Upside (Analyst Target) | 330.1% | 371.7% | 45.4% | |
Fair Value Upside | Unlock | 46.4% | 7.7% | Unlock |
Analysts' Recommendations
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 8.000
(+330.11% Upside)
People Also Watch
FAQ
What Is the Avenue Therapeutics (ATXI) Stock Price Today?
The Avenue Therapeutics stock price today is 1.86
What Stock Exchange Does Avenue Therapeutics Trade On?
Avenue Therapeutics is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Avenue Therapeutics?
The stock symbol for Avenue Therapeutics is "ATXI."
What Is the Avenue Therapeutics Market Cap?
As of today, Avenue Therapeutics market cap is 3.54M.
What is Avenue Therapeutics Earnings Per Share?
The Avenue Therapeutics EPS is -20.51.
From a Technical Analysis Perspective, Is ATXI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.